Murine regulatory T cells contain hyperproliferative and death-prone subsets with differential ICOS expression.

Murine regulatory T cells contain hyperproliferative and death-prone subsets with differential ICOS expression.
复制标题

鼠调节T细胞含有具有差异ICOS表达的高增殖性和易死的子集。

DOI:
10.4049/jimmunol.1102448
复制
发表时间:
2012-02-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
通讯作者:
Zhong XP
Zhong XP
中科院分区:
其他
文献类型:
--
作者:
Chen Y;Shen S;Gorentla BK;Gao J;Zhong XP

文献摘要

参考文献

被引文献

相似文献

调节性T细胞(Treg)对自我耐受至关重要。Treg在体外受T细胞受体(TCR)刺激后表现出低增殖的无能表型,但在体内却表现出旺盛的增殖,这一直是一个谜。我们在这里报道,与传统的T细胞(Tcon)不同,小鼠Treg细胞在体外和体内都容易死亡,但具有超增殖能力。在体外培养过程中,大多数Treg在有或没有TCR刺激的情况下死亡,这与内在死亡途径的组成性激活有关。然而,一小部分Treg群体对TCR刺激更敏感,特别是弱刺激,增殖比CD4+ Tcon更强烈,并且对激活诱导的细胞死亡有抵抗力。与Tcon相比,IL-2可增强Treg的增殖,但对cd28介导的共刺激的依赖性较低。我们进一步证明,存活和增殖的Treg是ICOS阳性,而易死亡的Treg是ICOS阴性。此外,ICOS+ Treg比ICOS−Treg具有更强的抑制活性。我们的数据表明,大量死亡有助于体外Treg的无能表型,并建议调节Treg存活作为治疗自身免疫性疾病和癌症的治疗策略。
Regulatory T cells (Treg) are crucial for self-tolerance. It has been an enigma that Treg exhibit an anergic phenotype reflected by hypo-proliferation in vitro following T cell receptor (TCR) stimulation but undergo vigorous proliferation in vivo. We report here that, different from conventional T cells (Tcon), murine Treg are prone to death but hyper-proliferative in vitro and in vivo. During in vitro culture, most Treg die with or without TCR stimulation, correlated with constitutive activation of the intrinsic death pathway. However, a small portion of the Treg population is more sensitive to TCR stimulation, particularly weak stimulation, proliferates more vigorously than CD4+ Tcon, and are resistant to activation induced cell death. Treg proliferation is enhanced by IL-2 but less dependent on CD28-mediated costimulation than Tcon. We demonstrate further that the surviving and proliferative Treg are ICOS positive while the death-prone Treg are ICOS negative. Moreover, ICOS+ Treg contain much stronger suppressive activity than ICOS− Treg. Our data indicates that massive death contributes to the anergic phenotype of Treg in vitro and suggest modulating Treg survival as a therapeutic strategy for treatment of autoimmune diseases and cancer.
DOI: 10.4049/jimmunol.181.4.2855
发表时间: 2008-08-15
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者:
Golovina TN;Mikheeva T;Suhoski MM;Aqui NA;Tai VC;Shan X;Liu R;Balcarcel RR;Fisher N;Levine BL;Carroll RG;Warner N;Blazar BR;June CH;Riley JL
通讯作者: Riley JL
DOI: 10.4049/jimmunol.174.5.3000
发表时间: 2005-03-01
影响因子: 4.4
作者:
Gajewska, BU;Tafuri, A;Jordana, M
通讯作者: Jordana, M
DOI: 10.1084/jem.20040179
发表时间: 2004-06-07
影响因子: 15.3
作者:
Herman, AE;Freeman, GJ;Benoist, C
通讯作者: Benoist, C
DOI: 10.1016/j.immuni.2007.01.011
发表时间: 2007-02-01
期刊: IMMUNITY
影响因子: 32.4
作者:
De Rosa, Veronica;Procaccini, Claudio;Matarese, Giuseppe
通讯作者: Matarese, Giuseppe
DOI: 10.4049/jimmunol.180.8.5448
发表时间: 2008-04-15
影响因子: 4.4
作者:
Akbari, Omid;Stock, Philippe;DeKruyff, Rosemarie H.
通讯作者: DeKruyff, Rosemarie H.